Results 21 to 30 of about 5,283,028 (221)

Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism

open access: yesInternational Journal of Molecular Sciences, 2022
Deficient acid β-glucocerebrosidase activity due to biallelic mutations in GBA1 results in Gaucher disease (GD). Patients with this lysosomal storage disorder exhibit a wide range of associated manifestations, spanning from virtually asymptomatic adults to infants with severe neurodegeneration.
Makaila L. Furderer   +3 more
openaire   +2 more sources

Gaucher Disease [PDF]

open access: yesEinstein (São Paulo), 2007
Although Gaucher disease is a rare disorder, recent developments in novel means for therapeutic intervention have invigorated both academic research and pharmaceutical industry discovery programmes. The common mutations found in the lysosomal enzyme deficient in Gaucher disease, beta-glucocerebrosidase, earmark these proteins for destruction by the ...
Guilherme Henrique Hencklain Fonseca   +1 more
doaj   +4 more sources

Gaucher-like Cells in Thalassemia Intermedia: Is It a Challenge?

open access: yesDiseases, 2023
We describe two cases of thalassemia intermedia (TI) patients with the presence of Gaucher-like cells in hematopoietic tissue biopsies, raising diagnostic dilemmas. The first is a 56-year-old female with bone lesions, splenomegaly, hypochromic microcytic
Veroniki Komninaka   +7 more
doaj   +1 more source

Gaucher disease type 1 first recognized in an elderly patient with thrombocytopenia and lung adenocarcinoma

open access: yesClinical Case Reports, 2019
Recognizing Gaucher disease in elderly patients can be challenging. We present a Gaucher disease type 1 case diagnosed in an elderly patient with thrombocytopenia and lung adenocarcinoma.
Wen Shuai   +5 more
doaj   +1 more source

Predicted responsiveness of Gaucher disease mutations.

open access: yes, 2021
Predicted responsiveness of Gaucher disease mutations.
Jaie Woodard (8377059)   +2 more
core   +1 more source

Structural properties of Gaucher disease mutations.

open access: yes, 2021
Structural properties of Gaucher disease mutations.
Jaie Woodard (8377059)   +2 more
core   +1 more source

Reversal of life-threatening hepatopulmonary syndrome in Gaucher disease by imiglucerase enzyme replacement therapy

open access: yesMolecular Genetics and Metabolism Reports, 2019
Advanced liver disease complicated by hepatopulmonary syndrome is a recognized complication of Gaucher disease. Macrophage-targeted, recombinant enzyme replacement therapy is effective in reversing clinical manifestations attributed to the accumulation ...
Amal El Beshlawy   +3 more
doaj   +1 more source

The definition of neuronopathic Gaucher disease [PDF]

open access: yes, 2020
Neuronopathic Gaucher disease (nGD) has a very wide clinical and genotypic spectrum. However, there is no consensus definition of nGD, including no description of how best to diagnostically separate the acute form-Gaucher type 2-from the subacute or ...
Rolfs, A   +41 more
core   +1 more source

A reappraisal of Gaucher disease-diagnosis and disease management algorithms

open access: yes, 2010
Type 1 (non-neuronopathic) Gaucher disease was the first lysosomal storage disorder for which an effective enzyme replacement therapy was developed and it has become a prototype for treatments for related orphan diseases.
Maria Domenica Cappellini   +35 more
core   +2 more sources

Cytokines in Gaucher disease: Role in the pathogenesis of bone and pulmonary disease

open access: yesEgyptian Journal of Medical Human Genetics, 2015
Gaucher disease (GD) is the most frequently encountered lysosomal storage disease caused by inborn defects of the membrane-bound lysosomal enzyme, acid β-glucosidase or glucocerebrosidase.
Azza A.G. Tantawy
doaj   +1 more source

Home - About - Disclaimer - Privacy